Berries, mixed foods may raise Listeria risk for LTC facilities, outbreak analysis finds
By
Alicia Lasek
Oct 19, 2021
Long-term care facilities may be susceptible to listeriosis outbreaks, investigators say. These infections tend to crop up as single but severe cases over a prolonged time period.
Clinical briefs for Wednesday, Oct. 20
By
Alicia Lasek
Oct 20, 2021
Minnesota to train National Guard soldiers to help in long-term care facilities … Male sex, older age tied to failed treatment for community-acquired pneumonia … Women, individuals with more education...
FDA approves first nasal spray for chronic dry eyes
By
Alicia Lasek
Oct 19, 2021
Sprayed twice daily into each nostril, Tyrvaya reduced eye dryness within four weeks in clinical trials. The medication will be available by prescription beginning in November, the developer says.
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
By
Alicia Lasek
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...
Nearly all staff are vaccinated in majority of Connecticut’s long-term care facilities
By
Alicia Lasek
Oct 19, 2021
One state is experiencing success with its COVID-19 vaccination mandate: Fully three quarters of LTC facilities in Connecticut have a 95% staff vaccination rate, its Department of Public Health announced...
Nursing home COVID cases, deaths trending downward, CDC’s latest data show
By
Alicia Lasek
Oct 18, 2021
Rates have steadily fallen since an uptick in September, according to data submitted by facilities to the agency’s National Healthcare Safety Network.
Heparin emerging as a lifesaver for moderately ill COVID patients
By
Alicia Lasek
Oct 18, 2021
High doses of the anticoagulant reduce the risk of developing the dangerous blood clots that are a hallmark of COVID-19, two new studies confirm.
FDA panel recommends second J&J coronavirus vaccine dose for adult recipients
By
Alicia Lasek
Oct 18, 2021
Independent experts have unanimously agreed that a full second dose of the drugmaker’s COVID-19 vaccine be offered to adults aged 18 years and older at least two months after receipt of the first...
Clinical briefs for Monday, Oct. 18
By
Alicia Lasek
Oct 18, 2021
Operators urged to provide more emotional support for nursing assistants after pandemic’s costly toll … Telehealth continues to substitute for in-person care for seniors, but rural use lags … Sleep...
FDA advisers recommend Moderna COVID booster for seniors, others at high risk
By
Alicia Lasek
Oct 15, 2021
In a unanimous vote, advisers agreed that vulnerable Moderna vaccine recipients should be offered a third shot. A half dose will be effective and will help protect against side effects, the drugmaker says.